SE0203747D0 - New use - Google Patents
New useInfo
- Publication number
- SE0203747D0 SE0203747D0 SE0203747A SE0203747A SE0203747D0 SE 0203747 D0 SE0203747 D0 SE 0203747D0 SE 0203747 A SE0203747 A SE 0203747A SE 0203747 A SE0203747 A SE 0203747A SE 0203747 D0 SE0203747 D0 SE 0203747D0
- Authority
- SE
- Sweden
- Prior art keywords
- new use
- deoxypodophyllotoxin
- picropodophyllin
- glioblastoma
- neuroblastoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to the use of certain cyclolignans as specific inhibitors of the insulin-like growth factor-1 receptor for treatment of the malignant diseases neuroblastoma, myeloma, glioblastoma and lung cancer, as well as benign tumours. Preferred compounds are picropodophyllin and deoxypodophyllotoxin.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203747A SE0203747D0 (en) | 2002-12-18 | 2002-12-18 | New use |
PCT/SE2003/002012 WO2004055022A1 (en) | 2002-12-18 | 2003-12-18 | Use of cyclolignans as inhibitors of igf-1 receptor for treatment of malignat diseases |
AU2003288858A AU2003288858A1 (en) | 2002-12-18 | 2003-12-18 | Use of cyclolignans as inhibitors of igf-1 receptor for treatment of malignat diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203747A SE0203747D0 (en) | 2002-12-18 | 2002-12-18 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0203747D0 true SE0203747D0 (en) | 2002-12-18 |
Family
ID=20289900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0203747A SE0203747D0 (en) | 2002-12-18 | 2002-12-18 | New use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003288858A1 (en) |
SE (1) | SE0203747D0 (en) |
WO (1) | WO2004055022A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080171318A1 (en) * | 2004-09-30 | 2008-07-17 | Epigenomics Ag | Epigenetic Methods and Nucleic Acids for the Detection of Lung Cell Proliferative Disorders |
WO2009100349A1 (en) | 2008-02-09 | 2009-08-13 | The Trustees Of Columbia University In The City Of New York | Analogues of (-)-picropodophyllin, synthesis and uses thereof |
WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
US20130331445A1 (en) * | 2010-10-08 | 2013-12-12 | Axelar Ab | Picropodophyllin Monohydrate or Polymorph A in Cancer Therapy |
CN103269700A (en) | 2010-10-08 | 2013-08-28 | 阿克塞拉公司 | Picropodophyllin polymorphs b or c for use in cancer therapy |
WO2013132263A1 (en) * | 2012-03-09 | 2013-09-12 | Axelar Ab | Picropodophyllin derivatives for use in therapy |
KR102090554B1 (en) * | 2018-04-13 | 2020-03-18 | 한국원자력의학원 | Radiosensitizer containing β-Apopicropodophyllin as an active ingredient |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102168D0 (en) * | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
-
2002
- 2002-12-18 SE SE0203747A patent/SE0203747D0/en unknown
-
2003
- 2003-12-18 WO PCT/SE2003/002012 patent/WO2004055022A1/en not_active Application Discontinuation
- 2003-12-18 AU AU2003288858A patent/AU2003288858A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003288858A1 (en) | 2004-07-09 |
WO2004055022A1 (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2017019I1 (en) | Diarylhydantoin compound, pharmaceutical composition and use thereof | |
BRPI0510177B8 (en) | compound, pharmaceutical composition and use thereof | |
DE60318177D1 (en) | RHO-KINASE INHIBITORS | |
NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
EA201071100A1 (en) | Pyridyl-containing SIGNAL TRANSMISSION TRANSMITTER INHIBITORS THROUGH HEDGEHOG | |
PA8571001A1 (en) | 2- (2,6-DICLOROPHENYL) -DIARYLIMIDAZOLS | |
EA200501504A1 (en) | Cannabinoid receptor ligands and their use | |
EA200701930A1 (en) | Derivatives of pyrimidine for the treatment of hyperproliferative disorders | |
EA200870415A1 (en) | QUINAZOLINS TO INHIBIT PDK 1 | |
UA116188C2 (en) | PHOSPHATIDYLINOSITE-3-KINASE INHIBITORS AND METHODS OF USE | |
EA200802213A1 (en) | METHODS OF TREATING BLOOD DISEASES | |
EA200501430A1 (en) | Cannabinoid receptor ligands and their use | |
EA201890903A1 (en) | CONNECTIONS OF PERIDEL INHIBITORS OF TRANSMISSION OF SIGNALS BY HEDGEHOG PROTEIN, METHOD OF THEIR RECEIVING, COMPOSITION AND METHODS OF TREATING CANCER AND INHIBITING ANGIOGENESIS AND HEDGEHOG IN CELLS | |
MX2007002269A (en) | Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain. | |
MX2007011545A (en) | Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors. | |
ATE458487T1 (en) | TUMOR TREATMENT WITH GLIOTOXIN DERIVATIVES | |
EA201170617A1 (en) | PYRAZOLYLAMINOPIRIDINE AS FAK INHIBITORS | |
MY148617A (en) | 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them | |
EA201170344A1 (en) | AZAINDOL IAP INHIBITORS | |
ATE549024T1 (en) | QUINAZOLINE POTASSIUM CHANNEL INHIBITORS | |
SE0203747D0 (en) | New use | |
EA200901180A1 (en) | DERIVATIVES OF TETRAPHYDROCHINOLINE AND THEIR APPLICATION FOR THE TREATMENT OF MALIGNANT NORMAL FORMATION | |
DE60316128D1 (en) | N-sulfonylurea APOPTOSIS PROMOTERS | |
ATE419242T1 (en) | PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS | |
SE0301202D0 (en) | New use and new compounds |